The L3 loop: a structural motif determining specific interactions between SMAD proteins and TGF‐β receptors

Signal transduction specificity in the transforming growth factor‐β (TGF‐β) system is determined by ligand activation of a receptor complex which then recruits and phosphorylates a subset of SMAD proteins including Smads 1 and 2. These then associate with Smad4 and move into the nucleus where they regulate transcription. We have identified a discrete surface structure in Smads 1 and 2 that mediates and specifies their receptor interactions. This structure is the L3 loop, a 17 amino acid region that protrudes from the core of the conserved SMAD C‐terminal domain. The L3 loop sequence is invariant among TGF‐β‐ and bone morphogenetic protein (BMP)‐activated SMADS, but differs at two positions between these two groups. Swapping these two amino acids in Smads 1 and 2 induces a gain or loss, respectively, in their ability to associate with the TGF‐β receptor complex and causes a switch in the phosphorylation of Smads 1 and 2 by the BMP and TGF‐β receptors, respectively. A full switch in phosphorylation and activation of Smads 1 and 2 is obtained by swapping both these two amino acids and four amino acids near the C‐terminal receptor phosphorylation sites. These studies identify the L3 loop as a determinant of specific SMAD–receptor interactions, and indicate that the L3 loop, together with the C‐terminal tail, specifies SMAD activation.

[1]  C. J. Gimeno,et al.  Vascular MADs: two novel MAD-related genes selectively inducible by flow in human vascular endothelium. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[2]  K. Miyazono,et al.  Smad6 inhibits signalling by the TGF-beta superfamily. , 1997, Nature.

[3]  Scott E. Kern,et al.  DPC4, A Candidate Tumor Suppressor Gene at Human Chromosome 18q21.1 , 1996, Science.

[4]  Irene L Andrulis,et al.  MADR2 Maps to 18q21 and Encodes a TGFβ–Regulated MAD–Related Protein That Is Functionally Mutated in Colorectal Carcinoma , 1996, Cell.

[5]  J. Massagué,et al.  Transforming growth factor-beta inhibition of epithelial cell proliferation linked to the expression of a 53-kDa membrane receptor. , 1989, The Journal of biological chemistry.

[6]  J. Massagué,et al.  Smad6 inhibits BMP/Smad1 signaling by specifically competing with the Smad4 tumor suppressor. , 1998, Genes & development.

[7]  Richard Treisman,et al.  Transcriptional Regulation by Extracellular signals: Mechanisms and Specificity , 1995, Cell.

[8]  W. Gelbart,et al.  Mothers against dpp participates in a DDP/TGF-beta responsive serine-threonine kinase signal transduction cascade. , 1997, Development.

[9]  W. Vale,et al.  Smad8 mediates the signaling of the receptor serine kinase , 1997 .

[10]  Xiao-Fan Wang,et al.  Mammalian dwarfins are phosphorylated in response to transforming growth factor beta and are implicated in control of cell growth. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[11]  J. Massagué TGFβ Signaling: Receptors, Transducers, and Mad Proteins , 1996, Cell.

[12]  J. Massagué,et al.  Mutations increasing autoinhibition inactivate tumour suppressors Smad2 and Smad4 , 1997, Nature.

[13]  P. Hoodless,et al.  MADR1, a MAD-Related Protein That Functions in BMP2 Signaling Pathways , 1996, Cell.

[14]  R. Derynck,et al.  Heteromeric and homomeric interactions correlate with signaling activity and functional cooperativity of Smad3 and Smad4/DPC4 , 1997, Molecular and cellular biology.

[15]  Minoru Watanabe,et al.  Smad4 and FAST-1 in the assembly of activin-responsive factor , 1997, Nature.

[16]  J. Wrana,et al.  The MAD-Related Protein Smad7 Associates with the TGFβ Receptor and Functions as an Antagonist of TGFβ Signaling , 1997, Cell.

[17]  Kirby D. Johnson,et al.  Drosophila Mad binds to DNA and directly mediates activation of vestigial by Decapentaplegic , 1997, Nature.

[18]  T. Musci,et al.  The tumor suppressor Smad4/DPC 4 as a central mediator of Smad function , 1997, Current Biology.

[19]  R. Lotan,et al.  DPC4, a candidate tumor suppressor gene, is altered infrequently in head and neck squamous cell carcinoma. , 1996, Cancer research.

[20]  R. Derynck,et al.  Receptor-associated Mad homologues synergize as effectors of the TGF-β response , 1996, Nature.

[21]  A. Hata,et al.  TGF-β signalling through the Smad pathway , 1997 .

[22]  J. Baker,et al.  A novel mesoderm inducer, Madr2, functions in the activin signal transduction pathway. , 1996, Genes & development.

[23]  J. Wrana,et al.  MAD-related proteins in TGF-β signalling , 1996 .

[24]  G. Thomsen Xenopus mothers against decapentaplegic is an embryonic ventralizing agent that acts downstream of the BMP-2/4 receptor. , 1996, Development.

[25]  J. Massagué,et al.  The TGF-beta family mediator Smad1 is phosphorylated directly and activated functionally by the BMP receptor kinase. , 1997, Genes & development.

[26]  C. Heldin,et al.  Identification of Smad2, a Human Mad-related Protein in the Transforming Growth Factor β Signaling Pathway* , 1997, The Journal of Biological Chemistry.

[27]  J. Massagué,et al.  Partnership between DPC4 and SMAD proteins in TGF-β signalling pathways , 1996, Nature.

[28]  J. Graff,et al.  Xenopus Mad Proteins Transduce Distinct Subsets of Signals for the TGFβ Superfamily , 1996, Cell.

[29]  P. Hoodless,et al.  MADR2 Is a Substrate of the TGFβ Receptor and Its Phosphorylation Is Required for Nuclear Accumulation and Signaling , 1996, Cell.

[30]  Yigong Shi,et al.  A structural basis for mutational inactivation of the tumour suppressor Smad4 , 1997, Nature.

[31]  J. Massagué,et al.  A human Mad protein acting as a BMP-regulated transcriptional activator , 1996, Nature.

[32]  T. Lecuit,et al.  Mad acts downstream of Dpp receptors, revealing a differential requirement for dpp signaling in initiation and propagation of morphogenesis in the Drosophila eye. , 1996, Development.

[33]  R. W. Padgett,et al.  Caenorhabditis elegans genes sma-2, sma-3, and sma-4 define a conserved family of transforming growth factor beta pathway components. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[34]  J. Massagué,et al.  Mechanism of TGFβ receptor inhibition by FKBP12 , 1997, The EMBO journal.

[35]  H. Hishigaki,et al.  Cloning and characterization of a novel member of the human Mad gene family (MADH6). , 1997, Genomics.

[36]  T. Pawson,et al.  Signaling through scaffold, anchoring, and adaptor proteins. , 1997, Science.

[37]  C. Heldin,et al.  Identification of Smad7, a TGFβ-inducible antagonist of TGF-β signalling , 1997, Nature.

[38]  C. Heldin,et al.  Identification of Smad7, a TGFbeta-inducible antagonist of TGF-beta signalling. , 1997, Nature.

[39]  J. Massagué [17] Identification of receptor for type-β transforming growth factor , 1987 .

[40]  K. Miyazono,et al.  Smad6 inhibits signalling by the TGF-β superfamily , 1997, Nature.

[41]  R. Derynck,et al.  Intracellular signalling: The Mad way to do it , 1996, Current Biology.

[42]  T. Tabata,et al.  Daughters against dpp modulates dpp organizing activity in Drosophila wing development , 1997, Nature.

[43]  J. Sekelsky,et al.  Genetic characterization and cloning of mothers against dpp, a gene required for decapentaplegic function in Drosophila melanogaster. , 1995, Genetics.

[44]  M. Kretzschmar,et al.  Opposing BMP and EGF signalling pathways converge on the TGF-β family mediator Smad1 , 1997, Nature.

[45]  J. Massagué,et al.  Dual role of the Smad4/DPC4 tumor suppressor in TGFbeta-inducible transcriptional complexes. , 1997, Genes & development.

[46]  J. Massagué,et al.  Smad 6 inhibits BMP / Smad 1 signaling by specifically competing with the Smad 4 tumor suppressor , 1998 .